DUBLIN, June 9, 2023 /PRNewswire/ — The “DNA and Gene Chip Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global DNA and gene chip market is expected to grow from $6.47 billion in … Read more
DALLAS, June 9, 2023 /PRNewswire/ — Valor Healthcare is proud to announce its selection as one of four companies awarded a position on Veterans Affairs’ (VA) eight-year, $1.032 billion contract to provide Remote Patient Monitoring (RPM) and Home Telehealth (HT) services for veterans. VA’s Office of Connected Care will deploy the systems and tools needed … Read more
Pictured left to right, Dr. Robert E. W. Hancock and Shaikh Isa bin Khalid Al-Khalifa sign the joint venture’s definitive agreement. VANCOUVER, BC, June 9, 2023 /PRNewswire/ – Pursuant to the signing of a Letter of Intent (LOI) in December 2022, Asep Medical Holdings Inc. (“Asep Inc.” or the “Company”) (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is … Read more
Peripheral and Central Nervous System Drugs Advisory Committee voted based on data from large global confirmatory Phase 3 Clarity AD clinical trial in patients living with early Alzheimer’s disease The PDUFA action date for traditional approval of LEQEMBI has been set for July 6, 2023, with designation of priority review LEQEMBI received accelerated approval from the … Read more
DUBLIN, June 9, 2023 /PRNewswire/ — The “Global Medical Display Market by Technology (LED-Backlit LCD Displays, CCFL-Backlit LCD Displays, OLED Displays), Panel Size (Under 22.9 inch panels, 23.9-26.9 inch panels, 27-41.9 inch panels), Resolution, Display Color, Application – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The global market for Medical Display Market … Read more
DUBLIN, June 9, 2023 /PRNewswire/ — The “Global Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer, Gastrointestinal, Infectious), Type (Peptide, Live Biotherapeutic Product, FMT), and Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global human microbiome market is projected to reach USD 1.7 billion by … Read more
CHICAGO, June 9, 2023 /PRNewswire/ — Today, an Advisory Committee to the Food and Drug Administration (FDA) unanimously endorsed the efficacy and clinical benefit of lecanemab (Leqembi™, Eisai) as part of the traditional approval process for this treatment. “The Alzheimer’s Association welcomes and celebrates this action by the FDA Advisory Committee to support traditional approval … Read more
The FDA Advisory Committee’s endorsement of Leqembi ushers in a new era for Alzheimer’s therapeutics Anti-amyloids are not the panacea, underscoring the need to develop novel drugs that can be used in combination therapy approaches NEW YORK, June 9, 2023 /PRNewswire/ — Today, the FDA Peripheral and Central Nervous System Drugs Advisory Committee unanimously voted … Read more
DUBLIN, June 9, 2023 /PRNewswire/ — The “Global Opioid Induced Constipation Market by Active Ingredients, Drug Class, Mode of Administration, Distribution Channel – Cumulative Impact of High Inflation – Forecast 2023-2030” report has been added to ResearchAndMarkets.com’s offering. The Global Opioid Induced Constipation Market was estimated at USD 62.12 million in 2022, and is expected to … Read more
Partnership Enhances Its Adparo® Services Division, Improves Patient Access to Care, and Expands Solution Offering CRANBERRY TOWNSHIP, Pa., June 9, 2023 /PRNewswire/ — Annexus Health, Inc., the leading healthcare technology company that is revolutionizing the patient access journey through its innovative solutions, today announced its partnership with healthcare management solutions provider Omega Healthcare. Ranked among … Read more